SANUWAVE Health Inc (OTC: SNWV) is a medical device company that develops and commercializes devices subject to FDA regulation. Revenue is transactional, generated through the sale and use of medical devices, with third-party reimbursement anticipated as a component of the commercial model as described in the FY2025 10-K filed March 26, 2026. The company operates in the United States healthcare market and is subject to federal and state anti-kickback statutes, FDA oversight, and healthcare fraud and abuse laws applicable to medical device manufacturers. SNWV does not pay cash dividends and has stated its intent to retain any future earnings to finance operations. As of the FY2025 filing, Morgan Frank serves as Chief Executive Officer. The company's capital structure includes debt with associated issuance costs and discounts, derivative liabilities, and stock-based compensation, indicating a leveraged balance sheet with no dividend distributions.
Source: SEC 10-K, filed 2026-03-26
Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Streamex Corp Microbot Medical Inc Sonendo, Inc. electroCore, Inc. INVACARE HOLDINGS Corp Nemaura Medical Inc. Precision Optics Corporation Inc Vivani Medical Inc
Loading...